Capital Cell — 2018 Investments
1 investments dated 2018 · listed companies and verified rows first · show all
MJN Neuroserveismjn.catinJan 2018
mjn develops neurological monitoring technology solutions for patients with epilepsy and other neurological disorders.
AI & Machine LearningHealthtechMedical Devices
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
